From Casetext: Smarter Legal Research

Sun Pharm. Indus. v. Incyte Corp.

United States Court of Appeals, Federal Circuit
Nov 16, 2023
No. 2019-2011 (Fed. Cir. Nov. 16, 2023)

Opinion

2019-2011

11-16-2023

SUN PHARMACEUTICAL INDUSTRIES, INC., F/D/B/A CONCERT PHARMACEUTICALS, INC. Appellant v. INCYTE CORPORATION, Appellee KATHERINE K. VIDAL, UNDER SECRETARY OF COMMERCE FOR INTELLECTUAL PROPERTY AND DIRECTOR OF THE UNITED STATES PATENT AND TRADEMARK OFFICE, Intervenor


Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2017-01256.

MANDATE

In accordance with the judgment of this Court, entered August 22, 2023, and pursuant to Rule 41 of the Federal Rules of Appellate Procedure, the formal mandate is hereby issued.


Summaries of

Sun Pharm. Indus. v. Incyte Corp.

United States Court of Appeals, Federal Circuit
Nov 16, 2023
No. 2019-2011 (Fed. Cir. Nov. 16, 2023)
Case details for

Sun Pharm. Indus. v. Incyte Corp.

Case Details

Full title:SUN PHARMACEUTICAL INDUSTRIES, INC., F/D/B/A CONCERT PHARMACEUTICALS, INC…

Court:United States Court of Appeals, Federal Circuit

Date published: Nov 16, 2023

Citations

No. 2019-2011 (Fed. Cir. Nov. 16, 2023)